iifl-logo-icon 1

Phaarmasia Ltd Share Price

63
(2.16%)
Jul 12, 2024|03:40:00 PM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Equities

Futures

Option

  • Open64.75
  • Day's High64.75
  • 52 Wk High61.67
  • Prev. Close61.67
  • Day's Low58.59
  • 52 Wk Low22.71
  • Turnover (lac)3.01
  • P/E0
  • Face Value10
  • Book Value8.87
  • EPS0
  • Mkt. Cap (Cr.)43.03
  • Div. Yield0
No Records Found

Phaarmasia Ltd KEY RATIOS

Sector

Pharmaceuticals

Open

64.75

Prev. Close

61.67

Turnover(Lac.)

3.01

Day's High

64.75

Day's Low

58.59

52 Week's High

61.67

52 Week's Low

22.71

Book Value

8.87

Face Value

10

Mkt Cap (₹ Cr.)

43.03

P/E

0

EPS

0

Divi. Yield

0

Phaarmasia Ltd Corporate Action

17 May 2024

12:00 AM

Board Meeting

Agenda : Audited Result

arrow

13 Jun 2023

12:00 AM

AGM

Announcement Date: 13 Jun, 2023

arrow

Phaarmasia Ltd NEWS AND UPDATE

No data found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Phaarmasia Ltd SHAREHOLDING SNAPSHOT

13 Jul, 2024|10:49 AM
  • Foreign Promoter
  • Indian Promoter
  • Institutions
  • Non Institutions
  • Custodies

Promoter- 73.51%

Foreign: 0.00%

Indian: 73.51%

Non-Promoter- 0.05%

Institutions: 0.05%

Non-Institutions: 26.42%

Custodian: 0.00%

Share Price

Phaarmasia Ltd FINANCIALS

Balance Sheet

Profit & Loss

Cash Flow

Ratios

Results

Loading...
Y/e 31 Mar( In .Cr)Mar-2023Mar-2022Mar-2021Mar-2020

Equity Capital

6.83

6.83

6.83

6.83

Preference Capital

0

0

0

0

Reserves

3.98

5.23

6.83

6.58

Net Worth

10.81

12.06

13.66

13.41

Minority Interest

View Balance Sheet
Loading...
Y/e 31 Mar( In .Cr)Mar-2021Mar-2020Mar-2018Mar-2017

Revenue

19.89

24.45

20.17

14.35

yoy growth (%)

-18.64

21.18

40.52

-33.54

Raw materials

-14.57

-17.79

-10.85

-6.73

As % of sales

73.27

72.76

53.78

46.88

Employee costs

-1.49

-1.58

-1.81

-1.54

View Profit & Loss
Loading...
Y/e 31 Mar( In .Cr)Mar-2021Mar-2020Mar-2018Mar-2017

Profit before tax

0.47

0.96

0.67

0.26

Depreciation

-0.34

-0.39

-0.46

-0.44

Tax paid

-0.16

-0.42

-0.1

-0.1

Working capital

0.19

2.02

0.06

0.41

Other operating items

View Cash Flow
Loading...
Y/e 31 MarMar-2021Mar-2020Mar-2018Mar-2017

Growth matrix (%)

Revenue growth

-18.64

21.18

40.52

-33.54

Op profit growth

-107.56

24.37

397.72

-39.1

EBIT growth

-50.83

38.23

162.62

7.53

Net profit growth

-42.2

-5.76

252.55

289.14

View Ratios

No Record found

Phaarmasia Ltd Peer Comparison

Company Name
LTP
(₹)
P/E
(%)
Mkt.Cap
(₹Cr.)
NP Qtr
(₹Cr.)
Div.Yield
(%)
Sales Qtr
(₹.Cr)
Book Value
(₹)

Sun Pharmaceuticals Industries Ltd

SUNPHARMA

1,583.25

124.473,79,874.71867.60.855,536.9998.75

Divis Laboratories Ltd

DIVISLAB

4,581.35

77.171,21,620.455310.652,259507.93

Cipla Ltd

CIPLA

1,505.8

32.731,21,596.061,038.40.563,444.92346.41

Zydus Lifesciences Ltd

ZYDUSLIFE

1,164.3

33.971,17,155.821,405.20.263,172.6156.19

Dr Reddys Laboratories Ltd

DRREDDY

6,595.8

25.681,10,037.531,034.80.615,081.81,458.96

Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.

MORE ABOUT Phaarmasia Ltd

Management

Register Office

Registrar Office

Non Executive Director

Vinay Ramakant Sapte

Non Executive Director

Maneesh R Sapte

Whole-time Director

Y N Bhaskara Rao

Non Executive Director

Rashmi V Sapte

Independent Director

PRAVIN M. HEGDE

Independent Director

Ajit G Jamkhandikar

Company Sec. & Compli. Officer

Urvashi Bhatia

Registered Office


Tel: -

Website: -

Email: -

Registrar Office


Tel: -

Website: -

Email: -

Summary

Incorporated in 1981, Phaarmasia Limited (unit-I) is the part of the Maneesh Pharmaceutical Limited, with its headquarters and marketing office in Mumbai. M/s Phaarmasia Limited Unit-II was established in 1993-94. The Company is engaged in manufacturing and marketing of Oral contraceptive tablets with various therapeutic dosage combinations along with iron tablets for Ministry of Health & Family Welfare and for Exports. The plant is situated in a hygienic environment; free from dust, smoke, chemical & biological emission. Phaarmasia Ltd. Is an independent State-of-the-art-manufacturing unit having manufacturing facility of international standards with manufacturing capacity of more than 30 million units per annum. During the year 2000, the company became a Sick Industrial Company under SICA and therefore the same was referred to the BIFR.During past a few decades, Phaarmasia mastered and manufactured wide range of Pharmaceutical Formulations at a WHO-GMPcertified and ISO 9001-certified manufacturing facility.
Read More

Company FAQs

What is the Phaarmasia Ltd share price today?

Down Arrow

The Phaarmasia Ltd shares price on BOMBAY STOCK EXCHANGE (BSE) is Rs.₹63 today.

What is the Market Cap of Phaarmasia Ltd?

Down Arrow

Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Phaarmasia Ltd is ₹43.03 Cr. as of 12 Jul ‘24

What is the PE and PB ratio of Phaarmasia Ltd?

Down Arrow

The PE and PB ratios of Phaarmasia Ltd is 0 and 6.95 as of 12 Jul ‘24

What is the 52 Week High and Low of Phaarmasia Ltd?

Down Arrow

The 52-week high/low is the highest and lowest price at which a Phaarmasia Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Phaarmasia Ltd is ₹22.71 and ₹61.67 as of 12 Jul ‘24

What is the CAGR of Phaarmasia Ltd?

Down Arrow

Phaarmasia Ltd's CAGR for 5 Years at 24.22%, 3 Years at 24.64%, 1 Year at 150.18%, 6 Month at 85.64%, 3 Month at 105.22% and 1 Month at 59.19%.

What is the shareholding pattern of Phaarmasia Ltd?

Down Arrow

The shareholding pattern of Phaarmasia Ltd is as follows:
Promoters - 73.51 %
Institutions - 0.06 %
Public - 26.43 %

Knowledge Centerplus
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Securities Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Knowledge Centerplus

Follow us on

facebooktwitterrssyoutubeinstagramlinkedin

2024, IIFL Securities Ltd. All Rights Reserved

ATTENTION INVESTORS
  • Prevent Unauthorized Transactions in your demat / trading account Update your Mobile Number/ email Id with your stock broker / Depository Participant. Receive information of your transactions directly from Exchanges on your mobile / email at the end of day and alerts on your registered mobile for all debits and other important transactions in your demat account directly from NSDL/ CDSL on the same day." - Issued in the interest of investors.
  • KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
  • No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.

RISK DISCLOSURE ON DERIVATIVES
  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to Rs. 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Copyright © IIFL Securities Ltd. All rights Reserved.

Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.